Nature of protective immunity to Francisella tularensis
- PMID: 2665002
Nature of protective immunity to Francisella tularensis
Abstract
Tularemia is caused by the facultative intracellular bacterium Francisella tularensis. Attenuated live vaccines, such as F. tularensis LVS (live vaccine strain), afford good--although not complete--protection; how to judge the degree of this protection has long been a problem. Both natural infection and vaccination result in immunospecific and long-lasting humoral and cell-mediated immunity. The latter is the crucial protective mechanism, whereas the humoral response protects only against strains of reduced virulence, such as those used in the vaccines. Immune serum has been used to screen for structures of F. tularensis with the ability to induce a protective immune response. This immune serum is, however, primarily directed toward antigens different from those involved in cell-mediated immunity. Serum antibodies from primed individuals recognize carbohydrate capsule antigens of F. tularensis, whereas T lymphocytes recognize membrane polypeptides of the organism. The preparation of membrane polypeptides from F. tularensis is now facilitated by the availability of a capsule-deficient mutant of F. tularensis LVS. In vitro, several membrane polypeptides of the mutant stimulate T lymphocytes from vaccinees and from naturally infected individuals. Further studies of the mechanisms of induction of protective immunity should focus on these membrane polypeptides.
Similar articles
-
The tularaemia vaccine.J Chem Technol Biotechnol. 1994 Apr;59(4):315-20. doi: 10.1002/jctb.280590402. J Chem Technol Biotechnol. 1994. PMID: 7764815 Review.
-
Vaccination strategies for Francisella tularensis.Adv Drug Deliv Rev. 2005 Jun 17;57(9):1403-14. doi: 10.1016/j.addr.2005.01.030. Adv Drug Deliv Rev. 2005. PMID: 15919131 Review.
-
Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.Vaccine. 2005 Apr 8;23(20):2680-6. doi: 10.1016/j.vaccine.2004.03.071. Vaccine. 2005. PMID: 15780452
-
Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).Microb Pathog. 2008 Feb;44(2):164-8. doi: 10.1016/j.micpath.2007.08.009. Epub 2007 Aug 21. Microb Pathog. 2008. PMID: 17904793
-
Francisella tularensis vaccines.FEMS Immunol Med Microbiol. 2007 Apr;49(3):315-23. doi: 10.1111/j.1574-695X.2007.00219.x. Epub 2007 Feb 22. FEMS Immunol Med Microbiol. 2007. PMID: 17316369 Review.
Cited by
-
Live attenuated tularemia vaccines: recent developments and future goals.Vaccine. 2013 Aug 2;31(35):3485-91. doi: 10.1016/j.vaccine.2013.05.096. Epub 2013 Jun 10. Vaccine. 2013. PMID: 23764535 Free PMC article. Review.
-
Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).PLoS One. 2010 Apr 2;5(4):e10000. doi: 10.1371/journal.pone.0010000. PLoS One. 2010. PMID: 20368994 Free PMC article.
-
An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells.Infect Immun. 2003 Oct;71(10):5940-50. doi: 10.1128/IAI.71.10.5940-5950.2003. Infect Immun. 2003. PMID: 14500514 Free PMC article.
-
Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages.Infect Immun. 2003 Aug;71(8):4642-6. doi: 10.1128/IAI.71.8.4642-4646.2003. Infect Immun. 2003. PMID: 12874344 Free PMC article.
-
Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.J Exp Med. 2003 Aug 4;198(3):379-89. doi: 10.1084/jem.20030687. Epub 2003 Jul 28. J Exp Med. 2003. PMID: 12885873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources